• Galmed Pharmaceuticals Reports Wider Q1 2026 Loss Amid Higher R&D Spending TipRanks Wed, 08 Jul 2026 20:51:58 GMT
• Galmed (NASDAQ: GLMD) posts Q1 loss and closes Colospan acquisition Stock Titan Wed, 08 Jul 2026 20:15:59 GMT
• Galmed Pharmaceuticals (GLMD) Plunges Nearly 12% as Stock Tests Key Support at $0.54 - Trading Ideas dars.gov.et Fri, 03 Jul 2026 20:31:17 GMT
• galmed pharmaceuticals ltd. actuals & estimates (nasdaq:glmd) TradingView Fri, 26 Jun 2026 04:51:31 GMT
• Enterprise value to EBITDA forward of Galmed Pharmaceuticals Ltd. – NASDAQ:GLMD TradingView Thu, 25 Jun 2026 20:25:22 GMT
• price to book forward of galmed pharmaceuticals ltd. – nasdaq:glmd TradingView Thu, 25 Jun 2026 20:25:20 GMT
• enterprise value to revenue forward of galmed pharmaceuticals ltd. – nasdaq:glmd TradingView Thu, 25 Jun 2026 20:10:39 GMT
• enterprise value to ebit forward of galmed pharmaceuticals ltd. – nasdaq:glmd TradingView Thu, 25 Jun 2026 20:00:09 GMT
• form 6k galmed pharmaceuticals ltd for: 22 june by investing.com Investing.com Nigeria Mon, 22 Jun 2026 12:00:19 GMT
• galmed announces restructured acquisition terms for colospan TipRanks Mon, 22 Jun 2026 11:35:00 GMT
• galmed (nasdaq: glmd) closes colospan acquisition; $3.3m cash, up to $2m earnout Stock Titan Mon, 22 Jun 2026 11:06:40 GMT
• Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercializa... PR Newswire Mon, 22 Jun 2026 07:00:00 GMT
• Galmed (NASDAQ: GLMD) completes Colospan acquisition with cash and earnout Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Galmed completes acquisition of medical device firm Colospan Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• press release: galmed pharmaceuticals ltd. announces restructured acquisition terms for colospan ltd., prioritizing cg-100 europea... Moomoo Mon, 22 Jun 2026 07:00:00 GMT
• galmed pharmaceuticals closes amended all-cash colospan acquisition with earnout structure TipRanks Mon, 22 Jun 2026 07:00:00 GMT
• galmed pharmaceuticals ltd (glmd) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 12:52:08 GMT
• galmed pharmaceuticals ltd (glmd) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 12:28:52 GMT
• galmed pharmaceuticals declines 3.37% as shares approach key support at $0.55 - put flow alert dars.gov.et Thu, 18 Jun 2026 07:00:00 GMT
• galmed pharmaceuticals ltd (glmd) institutional confidence TradingKey Thu, 18 Jun 2026 03:03:49 GMT
• galmed pharmaceuticals ltd (glmd) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 03:00:28 GMT
• galmed pharmaceuticals ltd (glmd) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 02:58:52 GMT
• galmed pharmaceuticals ltd (glmd) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 02:58:50 GMT
• galmed pharmaceuticals ltd (glmd) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 02:23:04 GMT
• galmed pharmaceuticals ltd (glmd) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 02:21:31 GMT
• glmd q4 2025 earnings: eps misses estimates amid pre-revenue phase - earnings power value newsline.com Tue, 16 Jun 2026 16:37:14 GMT
• maxim group maintains galmed pharmaceuticals(glmd.us) with hold rating, announces target price $0.55 富途牛牛 Tue, 16 Jun 2026 13:31:33 GMT
• Galmed Pharmaceuticals (GLMD) Slips 7.31% as Stock Tests Key Support at $0.54 - Supply Zone dars.gov.et Tue, 16 Jun 2026 07:00:00 GMT
• maxim group maintains galmed pharmaceuticals(glmd.us) with hold rating, announces target price $0.55 Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• glmd q4 2025 earnings: eps misses estimates by significant margin - ebitda analysis newsline.com Wed, 10 Jun 2026 21:47:18 GMT
• Galmed Pharmaceuticals: Colospan Acquisition Creates GI-Focused Platform Targeting $6 Billion Market Pulse 2.0 Wed, 10 Jun 2026 15:36:50 GMT
• Galmed acquires Colospan in $4.5M deal as it eyes $6B GI dx market Fierce Biotech Tue, 09 Jun 2026 07:00:00 GMT
• Galmed to Acquire Colospan for Colorectal Device Tech Medical Device and Diagnostic industry Tue, 09 Jun 2026 07:00:00 GMT
• Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market PR Newswire Mon, 08 Jun 2026 07:00:00 GMT
• Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Fi... Pharmaceutical Executive Mon, 08 Jun 2026 07:00:00 GMT
• Press Release: Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market Moomoo Mon, 08 Jun 2026 07:00:00 GMT
• Galmed’s $6B bet on Colospan device to ease life after colorectal surgery Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• Galmed Pharmaceuticals to Acquire Colospan, targeting $6B GI market grafa.com Mon, 08 Jun 2026 07:00:00 GMT
• Galmed to Acquire Colospan in Deal Expanding GI Medtech Platform citybiz Mon, 08 Jun 2026 07:00:00 GMT
• Incyte, Galmed, and Johnson & Johnson Announce Acquisitions Totaling $3 Billion geneonline.com Mon, 08 Jun 2026 07:00:00 GMT
• Galmed to acquire medical device firm Colospan for $4.5M Investing.com Mon, 08 Jun 2026 07:00:00 GMT
• Galmed Pharmaceuticals to Acquire Colospan and Commit $6 Million to European Expansion TipRanks Mon, 08 Jun 2026 07:00:00 GMT
• galmed pharmaceuticals (nasdaq: glmd) files amendment adding auditor consent Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• [6-k] galmed pharmaceuticals ltd. current report (foreign issuer) | glmd sec filing - form 6-k Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• galmed (nasdaq: glmd) registers 7.5m shares; agrees to buy colospan Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• galmed and tissue dynamics’ two-drug combination targets cardiac fibrosis TipRanks Tue, 02 Jun 2026 13:01:18 GMT
• Tissue Dynamics and Galmed Unveil Unknown Metabolic Pathway for Cardiac Fibrosis and Heart Failure which Supports the Development ... PR Newswire Tue, 02 Jun 2026 07:00:00 GMT
• galmed, tissue dynamics report preclinical cardiac fibrosis data Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• galmed and tissue dynamics reveal new metabolic target for cardiac fibrosis with aramchol combo TipRanks Tue, 02 Jun 2026 07:00:00 GMT
• galmed (glmd) and tissue dynamics show fourfold fibrosis cut in human heart organoids Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• galmed pharmaceuticals (glmd) rallies 11%: support and resistance in focus - opening range breakout The Legal Advocate Sat, 30 May 2026 02:40:03 GMT
• glmd q4 2025 earnings: eps misses estimates, stock surges on strategic developments - earnings forecast report newsline.com Fri, 29 May 2026 07:00:00 GMT
• galmed pharmaceuticals (glmd) rallies 11%: support and resistance in focus - rounding top newsline.com Fri, 29 May 2026 07:00:00 GMT
• galmed pharmaceuticals q4 2025 earnings: wider-than-expected loss amid pipeline progress - earnings surprise score newsline.com Fri, 29 May 2026 07:00:00 GMT
• galmed pharmaceuticals (glmd) surges 9.35% as shares test key resistance - outside reversal The Legal Advocate Fri, 29 May 2026 02:36:14 GMT
• galmed pharmaceuticals (glmd) surges 9.5%: testing key resistance at $0.71 - momentum trade The Legal Advocate Thu, 28 May 2026 18:34:34 GMT
• Galmed Pharmaceuticals (GLMD) Q4 2025 Earnings: Wider Loss Than Expected as Pre-Revenue Biotech Navigates Clinical Pipeline - Earn... dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• galmed pharmaceuticals (glmd) surges 9.35% as shares test key resistance - dip buy trade newsline.com Thu, 28 May 2026 07:00:00 GMT
• glmd q4 2025 earnings: eps misses estimates amid development stage uncertainty - tech earnings analysis newsline.com Mon, 25 May 2026 07:00:00 GMT
• glmd q4 2025 earnings: eps misses estimates as pre-revenue biotech faces challenges - earnings manipulation risk The Legal Advocate Sat, 23 May 2026 07:00:00 GMT
• glmd q4 2025 earnings: wider-than-expected loss as galmed continues clinical development - post-earnings drift The Legal Advocate Sat, 23 May 2026 01:43:37 GMT
• glmd q4 2025 earnings: wider-than-expected loss as galmed continues clinical development - revenue report The Legal Advocate Fri, 22 May 2026 07:00:00 GMT
• glmd stock price, quote & chart | galmed pharmaceuticals ltd (nasdaq:glmd) ChartMill Thu, 21 May 2026 07:00:00 GMT
• galmed pharmaceuticals (glmd) q4 2025 earnings miss: eps $-0.80 vs $-0.52 expected - {璐㈡姤鍓爣棰榼 Newser Tue, 19 May 2026 03:52:38 GMT
• galmed pharmaceuticals ltd expected to post a loss of 38 cents a share - earnings preview TradingView Mon, 18 May 2026 12:39:06 GMT
• galmed pharmaceuticals (glmd) down -1.33% — how low could it go? 2026-05-18 - triple top newsline.com Mon, 18 May 2026 07:00:00 GMT
• number of shareholders of galmed pharmaceuticals ltd. – fwb:gph TradingView Sat, 16 May 2026 17:00:50 GMT
• galmed pharmaceuticals (glmd) stock today: drops -2.85%, key support at $0.61 2026-05-15 - high dividend factor newsline.com Fri, 15 May 2026 07:00:00 GMT
• galmed pharmaceuticals (glmd) q4 2025 earnings: miss sparks concern - management guidance update newsline.com Fri, 15 May 2026 07:00:00 GMT
• galmed pharmaceuticals ltd. - ordinary shares (nq: glmd FinancialContent Fri, 15 May 2026 04:36:24 GMT
• galmed pharmaceuticals ltd. - ordinary shares (nq: glmd FinancialContent Thu, 14 May 2026 15:05:42 GMT
• galmed reports results from first-in-man pk study of aramchol meglumine TipRanks Thu, 14 May 2026 13:05:11 GMT
• Galmed Announces Results from First-in-Man Pharmacokinetics Study of Oral Formulation of Aramchol Meglumine (AM); 400mg AM Increas... PR Newswire Thu, 14 May 2026 07:00:00 GMT
• galmed tests once-a-day aramchol version with 5x absorption Stock Titan Thu, 14 May 2026 07:00:00 GMT
• galmed reports improved bioavailability in aramchol study Investing.com Thu, 14 May 2026 07:00:00 GMT
• aramchol pk study shows fivefold exposure gain, galmed (nasdaq: glmd) says Stock Titan Thu, 14 May 2026 07:00:00 GMT
• galmed reports fivefold bioavailability boost with new aramchol meglumine oral formulation TipRanks Thu, 14 May 2026 07:00:00 GMT
• galmed pharmaceuticals ltd. - ordinary shares (nq: glmd FinancialContent Tue, 12 May 2026 20:00:01 GMT
• galmed partnering with tissue dynamics to develop cardiac fibrosis platform TipRanks Thu, 07 May 2026 16:41:01 GMT
• tissue dynamics, galmed pharmaceuticals to develop human chronic cardiac fibrosis model Contract Pharma Wed, 06 May 2026 19:00:28 GMT
• galmed (nasdaq: glmd) teams with tissue dynamics on chronic cardiac fibrosis platform Stock Titan Wed, 06 May 2026 11:47:06 GMT
• tissue dynamics, galmed partner on cardiac fibrosis model Investing.com Wed, 06 May 2026 11:40:24 GMT
• tissue dynamics ltd. and galmed pharmaceuticals ltd. collaborate to develop human-centered chronic cardiac fibrosis platform marketscreener.com Wed, 06 May 2026 11:30:00 GMT
• 20,000 heart organoids: galmed builds a new fibrosis test bed Stock Titan Wed, 06 May 2026 11:30:00 GMT
• Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based T... PR Newswire Wed, 06 May 2026 07:00:00 GMT
• galmed pharmaceuticals partners with tissue dynamics on human cardiac fibrosis platform TipRanks Wed, 06 May 2026 07:00:00 GMT
• tissue dynamics and galmed pharmaceuticals ltd. (nasdaq: glmd) announce a strategic collaboration to jointly develop a chronic car... Bitget Wed, 06 May 2026 07:00:00 GMT
• tissue dynamics and galmed pharmaceuticals ltd. (nasdaq: glmd) announce a strategic collaboration to jointly develop a chronic car... Bitget Tue, 05 May 2026 20:40:31 GMT
• glmd stock shot up 85% pre-market after rising 27% in 5 days – what’s the latest on its parkinson’s disease therapy? MSN Wed, 29 Apr 2026 02:36:53 GMT
• galmed pharma shares jump 10% on cancer drug data: retail traders turn ‘extremely bullish’ MSN Tue, 28 Apr 2026 22:32:03 GMT
• glmd stock shot up 85% pre-market after rising 27% in 5 days – what’s the latest on its parkinson’s disease therapy? MSN Tue, 28 Apr 2026 06:34:27 GMT
• glmd stock shot up 85% pre-market after rising 27% in 5 days – what’s the latest on its parkinson’s disease therapy? msn.com Sun, 26 Apr 2026 14:15:41 GMT
• glmd stock shot up 85% pre-market after rising 27% in 5 days – what’s the latest on its parkinson’s disease therapy? MSN Sat, 25 Apr 2026 20:52:55 GMT
• glmd galmed pharmaceuticals posts wider than expected q4 2025 loss while shares rise nearly 2 percent. - roce Newser Sat, 25 Apr 2026 04:05:51 GMT
• galmed stock soars on brain-penetrating aramchol formulation msn.com Fri, 24 Apr 2026 07:03:30 GMT
• glmd galmed pharmaceuticals posts wider than expected q4 2025 loss while shares rise nearly 2 percent. - earnings yield spread newsline.com Fri, 24 Apr 2026 07:00:00 GMT
• glmd (galmed pharmaceuticals ltd. ordinary shares) posts wider than expected q4 2025 loss, shares dip nearly one percent. - meet e... Xã Thanh Hà Thu, 23 Apr 2026 08:19:49 GMT
• glmd (galmed pharmaceuticals ltd. ordinary shares) posts wider than expected q4 2025 loss, shares dip nearly one percent. - attent... Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 12:33:53 GMT
• glmd stock shot up 85% pre-market after rising 27% in 5 days – what’s the latest on its parkinson’s disease therapy? MSN Wed, 22 Apr 2026 08:44:26 GMT
• glmd stock shot up 85% pre-market after rising 27% in 5 days – what’s the latest on its parkinson’s disease therapy? MSN Fri, 17 Apr 2026 22:54:42 GMT
• glmd (galmed pharmaceuticals ltd. ordinary shares) posts wider than expected q4 2025 loss, shares dip nearly one percent. - short-... newsline.com Wed, 15 Apr 2026 07:00:00 GMT
• galmed pharmaceuticals (glmd) stock: beginner's guide (smart money outflows) 2026-04-15 - ma crossover newsline.com Wed, 15 Apr 2026 07:00:00 GMT
• galmed collaborates with tel aviv university to evaluate targeted therapy for metastatic brain cancers BioSpectrum Asia Wed, 15 Apr 2026 07:00:00 GMT
• maxim group maintains galmed pharmaceuticals(glmd.us) with hold rating 富途牛牛 Wed, 15 Apr 2026 07:00:00 GMT
• Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therap... PR Newswire Tue, 14 Apr 2026 07:00:00 GMT
• Galmed partners with Tel Aviv University on brain cancer therapy Investing.com Tue, 14 Apr 2026 07:00:00 GMT
• galmed pharmaceuticals teams with tel aviv university on aramchol for metastatic brain cancer TipRanks Tue, 14 Apr 2026 07:00:00 GMT
• galmed (nasdaq: glmd) and tel aviv university test aramchol for brain cancer Stock Titan Tue, 14 Apr 2026 07:00:00 GMT
• galmed announces research agreement with ramot at tel aviv university TipRanks Tue, 14 Apr 2026 07:00:00 GMT
• galmed pharmaceuticals ltd. and ramot at tel aviv university enter research collaboration agreement marketscreener.com Tue, 14 Apr 2026 07:00:00 GMT
• glmd stock shot up 85% pre-market after rising 27% in 5 days – what’s the latest on its parkinson’s disease therapy? MSN Tue, 14 Apr 2026 02:15:27 GMT
• galmed announces a collaboration agreement with tel aviv university to evaluate its scd1 inhibitor, aramchol, as a targeted therap... Bitget Mon, 13 Apr 2026 20:33:39 GMT
• glmd sec filings - galmed pharmaceu 10-k, 10-q, 8-k forms Stock Titan Sat, 11 Apr 2026 20:59:41 GMT
• galmed announces development of brain penetrating formulation of aramchol TipRanks Fri, 10 Apr 2026 08:14:14 GMT
• 12 health care stocks moving in friday's pre-market session Benzinga Fri, 10 Apr 2026 07:00:00 GMT
• glmd surges on unusual trading activity without any news — is this a genuine breakout or a potential trap? Bitget Thu, 09 Apr 2026 15:14:30 GMT
• Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol PR Newswire Thu, 09 Apr 2026 07:00:00 GMT
• Galmed Stock Soars On Brain-Penetrating Aramchol Formulation - Galmed Pharmaceuticals (NASDAQ:GLMD) Benzinga Thu, 09 Apr 2026 07:00:00 GMT
• Galmed Pharmaceuticals Maps Future with Aramchol Strategy timothysykes.com Thu, 09 Apr 2026 07:00:00 GMT
• Galmed Shares Double on Brain-Targeted Aramchol Breakthrough Startup Fortune Thu, 09 Apr 2026 07:00:00 GMT
• GLMD Stock Shot Up 55% Today After Rising 27% In 5 Days – What’s The Latest On Its Parkinson’s Disease Therapy? Stocktwits Thu, 09 Apr 2026 07:00:00 GMT
Galmed Pharmaceuticals Ltd(NASDAQ:GLMD) 
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with over...
Website: http://www.galmedpharma.com
Founded: 2000
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology